Arena Pharmaceuticals (ARNA)
Arena Pharmaceuticals Revenues: 2.189M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ARNA Revenues Rankings
| Overall | 3rd percentile | 4257 of 4425 |
| Sector | 17th percentile | 390 of 470 in Healthcare |
| Industry | 28th percentile | 94 of 132 in Biotechnology |
ARNA Revenues Range, Past 5 Years
| Minimum | 1.857M | Sep 2008 |
| Maximum | 7.629M | Sep 2010 |
| Average | 3.307M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these ARNA related companies
ARNA News
$AMRN Wow..Its official Pfizer offers $40.00 a share for AMARIN...Check out Yahoo Finance News!!! $GALE $ARNA
about 2 hours ago by kokoluck
about 2 hours ago by kokoluck
@sgdombrosky @CraigMac91 Put another way, if $ARNA didn't need to issue more shares since '06, Friday's close would be $24.70
about 2 hours ago by SlownSteady
about 2 hours ago by SlownSteady
@sgdombrosky @CraigMac91 If you adjust for the number of $ARNA shares outstanding, that 2006 price is really $5.02
about 3 hours ago by SlownSteady
about 3 hours ago by SlownSteady
@sgdombrosky @CraigMac91 $ARNA was over $20 ($20.68) in 2006, but has been issuing more shares since then: http://stks.co/403o
about 3 hours ago by SlownSteady
about 3 hours ago by SlownSteady
@CraigMac91 $40 IS POSSIBLE IN 2010 $ARNA WAS AT $24 A SHARE PRIOR TO FDA PANEL SO THEY CAN FLY
about 6 hours ago by sgdombrosky
about 6 hours ago by sgdombrosky
$FB Shorting 400 shares tues, $arna trying to add off of positive news on $kerx
about 6 hours ago by newkidontheblock
about 6 hours ago by newkidontheblock
$ARNA @newkidontheblock no problem brother sitting a long time smiling. good morning man. and to all.
about 6 hours ago by sgdombrosky
about 6 hours ago by sgdombrosky
$ARNA i think this is a good sign http://stks.co/3zyw nobody dumping shares
about 9 hours ago by markf
about 9 hours ago by markf
@SlownSteady re:Form 483, did you mean $ARNA or $AMRN? In the CC, AMRN talked about the one manufacturing supplier in Japan.
about 22 hours ago by Glopolon
about 22 hours ago by Glopolon
$ARNA Options plays going into June or people just buying the stock??
about a day ago by traderjflaw
about a day ago by traderjflaw
@Glopolon $ARNA $AMRN There was no AdComm for AMR-101 because the active ingredient isn't novel. The MoA has been described.
about 2 days ago by SlownSteady
about 2 days ago by SlownSteady
@SCarolinaguy $ARNA you're missing the teratogenic nature of the drug
about 2 days ago by SlownSteady
about 2 days ago by SlownSteady
$ARNA Side effect of topiramate $VVUS is hair loss. Fat guys may get skinny but may end up bald!
about 2 days ago by SCarolinaguy
about 2 days ago by SCarolinaguy
$vvus $arna is a small cap stock that has been trading from $ 2.00 to $6.00. They are not going to blow any one out of the water !
about 2 days ago by mrmizzou
about 2 days ago by mrmizzou
$ARNA the 6th estimate was a real lowball ($2.50) which skewed their average to a low of $6.88.
about 2 days ago by nick159
about 2 days ago by nick159
$ARNA Thanks, we figured it out earlier. My estimate came from yahoo financial (which was their mean/average of 6 analysts,not 5)
about 2 days ago by nick159
about 2 days ago by nick159
Arena Pharma (ARNA) Volatility Elevated, Shares Higher After Close of $70M Offering
May 22, 10:11AM Street Insider
May 22, 10:11AM Street Insider
Arena (ARNA) June volatility flat at 140, July is at 162 as shares give back gains after sharp rally
May 21, 1:17PM Street Insider
May 21, 1:17PM Street Insider
What’s Moving These Hot Stocks: Arena Pharmaceuticals and Renren
May 15, 2:17PM Wall St. Cheat Sheet
May 15, 2:17PM Wall St. Cheat Sheet
Arena Pharmaceuticals (ARNA) Volatility Swings as Traders Take Some Profit
May 15, 10:13AM Street Insider
May 15, 10:13AM Street Insider
Jefferies Sees a 3-6 Month Delay for Arena's (ARNA) Lorcaserin But Reiterates Buy Rating
May 14, 8:31AM Street Insider
May 14, 8:31AM Street Insider
Oppenheimer Maintains Perform Rating, Does Not Set PT for Arena Pharmaceuticals
May 11, 5:29PM Benzinga
May 11, 5:29PM Benzinga
Unusual 11 Mid-Day Movers 05/11: (ARNA) (RPRX) (GWAY) Higher; (ADY) (AMOT) (ASYS) Lower
May 11, 1:56PM Street Insider
May 11, 1:56PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ARNA | 6.00 | -0.04 | -0.66% | 1.083B |
| ARMH | 23.23 | +0.13 | +0.56% | 10.46B |
| ARLP | 58.99 | +0.17 | +0.29% | 2.176B |
| ARL | 2.69 | +0.00 | +0.00% | 30.99M |
| ARKR | 14.40 | +0.05 | +0.35% | 46.66M |
| ARK | 4.13 | +0.00 | +0.00% | |
| ARII | 21.36 | -0.65 | -2.95% | 456.04M |
| ASIA | 10.92 | -0.13 | -1.18% | 791.70M |
| ASI | 17.90 | +0.09 | +0.51% | 182.76M |
| ASH | 64.40 | -0.81 | -1.24% | 5.043B |